The road to a venture's financial success is a long and winding one. Capital infusions are important pit-stops along this journey to help a venture accelerate on its chosen path.
Most of the discussion in the ecosystem is on raising Series A or pre Series funding for a startup. At the same time every startup is founded with the hope that it will grow rapidly into a large and valuable business. Such growth will need substantial follow-on infusion of funds. In the past decade follow-on funding has been growing.
How does an entrepreneur go beyond Series A? What does it take? What needs to change and what stays the same? how long does it take and what can help?
This panel discussion focuses on key questions about such follow-on financing. When does a company start planning for Series B and beyond? How does it prepare an investment thesis that will attract investors into Series B and beyond? How does a company go about raisingfollow-on funding? What aspects of its business does a company focus on to elicit follow-on investors? What role does the Series A investor play in this part? What expectations do Series B and later stage investors have from the investment? What are some of the challenges in raising follow-on funding? How does the Series A investor and the subsequent stages manage the negotiation?
Get answers to these questions and more from an investor who has considerable experience in early stage venture investing, from an investor who specializes in later stage investing and from entrepreneurs who have successfully raised rounds beyond Series A.
The panel discussion will be preceded by a presentation of the results of an analysis of the VC and PE industry in India.
Details:
Venue : IIMB Auditorium
Date : Saturday, March 04, 2017
Time : 09:30 AM to 12:45 PM
Registration:
Speakers :
1.Prof G Sabarinathan : Faculty member, IIM Bangalore
2.Parag Dhol : Managing Director, Inventus Advisors India
3.Baskar Subramanian : Co-founder, Amagi Media Labs
4.Atul Gupta : Principal, Premji Invest
5.Aneesh Reddy : Co-founder & CEO, Capillary Technologies
Agenda :